Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema – A case report
Loading...
Date
2019-06
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
All India Ophthalmological Society
Abstract
A 13-year-old boy with a 4-year history of idiopathic pediatric uveitis and recurrent uveitic macular edema had failed conventional immunomodulatory therapy and presented to us with a vision of 6/24 [right eye (OD)] and 6/9 [left eye (OS)]. Fluorescein angiography showed diffuse vascular leakage along with cystoid macular edema (CME). Intravenous tocilizumab (10 mg/kg body) was given as 14 injections over 12 months. Repeat fluorescein angiography every 3 months showed a dramatic improvement in the vascular leakage and resolution of CME. At 13 months OF follow-up, vision had improved to 6/9p (OD) and 6/6(OS) with no recurrence of inflammation or CME.
Description
Keywords
Biologics, cystoid macular edema, idiopathic, pediatric uveitis, tocilizumab
Citation
Babu K, Sudheer B, Rao AP. Intravenous tocilizumab in idiopathic pediatric uveitis with refractory cystoid macular edema – A case report. Indian Journal of Ophthalmology. 2019 Jun; 67(6): 975-977